Delisting Determination,The Nasdaq Stock Market, LLC,
February 26, 2019, MiMedx Group, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of MiMedx Group, Inc.
(the Company), effective at the opening of the trading
session on March 8, 2019. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5250(c)(1).
The Company was notified of the Staffs determination on
July 20, 2018.  The Company appealed the determination
to a Hearing Panel. Upon review of the information provided
by the Company, the Panel issued a decision dated
September 20, 2018, granting the Company continued listing
pursuant to an exception that included several milestones
that the Company was required to meet, towards the goal
of regaining compliance with Listing Rule 5250(c)(1).
However, the Company was
unable to meet the exception milestones as required.
On November 6, 2018, the Panel issued a final delisting
determination and notified the Company that trading in the Companys
securities would be suspended on November 8, 2018.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company
became final on December 21, 2018.